CS
Publications
277
Views
149,297
Downloads
27,846
Supervised works
15
Items per page
1 - 277 of 277
Title Published in Access level OA Policy Year Views Downloads
Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North AmericaFrontiers in immunology
accessLevelPublic
2024 209 117
Cohort profile : the Swiss Mother and Child HIV Cohort Study (MoCHiV)BMJ open
accessLevelPublic
2024 5 8
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
accessLevelPublic
2023 88 107
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durabilityClinical microbiology and infection
accessLevelRestricted
2023 117 0
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 202 49
Influence of circadian clocks on adaptive immunity and vaccination responsesNature communications
accessLevelPublic
2023 313 87
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonatesFrontiers in immunology
accessLevelPublic
2023 134 105
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
accessLevelPublic
2022 244 160
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
accessLevelPublic
2022 114 20
Swiss recommendations on perioperative antimicrobial prophylaxis in childrenSwiss medical weekly
accessLevelPublic
2022 102 46
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker studyThe Lancet microbe
accessLevelPublic
2022 185 90
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controlsVaccine
accessLevelRestricted
2022 66 0
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 86 0
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
accessLevelPublic
2022 229 53
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 444 142
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosisInternational journal of molecular sciences
accessLevelPublic
2022 269 159
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 284 182
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 198 149
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
accessLevelRestricted
2021 279 1
Human Transcriptomic Response to the VSV-Vectored Ebola VaccineVaccines
accessLevelPublic
2021 158 85
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 381 38
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort studyMultiple Sclerosis and Related Disorders
accessLevelPublic
2021 343 164
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 437 267
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 523 320
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 313 163
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 406 216
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 418 256
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel DiseaseDigestion
accessLevelPublic
2021 147 89
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
accessLevelPublic
2021 79 65
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipientsVaccine
accessLevelRestricted
2021 224 0
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
accessLevelPublic
2021 340 196
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationNPJ Vaccines
accessLevelPublic
2020 477 138
Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology and Infection
accessLevelPublic
2020 523 315
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
accessLevelPublic
2020 457 407
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
accessLevelPublic
2020 379 201
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesNeurology: Neuroimmunology & Neuroinflammation
accessLevelPublic
2020 253 147
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent MannerFrontiers in immunology
accessLevelPublic
2020 277 147
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialClinical Microbiology and Infection
accessLevelPublic
2020 330 210
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 520 207
Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative reviewIntensive Care Medicine
accessLevelRestricted
2020 489 0
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology
accessLevelRestricted
2019 303 0
Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant RecipientsTransplantation
accessLevelRestricted
2019 425 1
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
accessLevelPublic
2019 323 259
Detectable Vesicular Stomatitis Virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humansThe Journal of Infectious Diseases
accessLevelPublic
2019 246 184
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort studyRheumatology
accessLevelRestricted
2019 309 0
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidatesAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
accessLevelRestricted
2019 448 3
Neonatal T follicular helper cells are lodged in a pre-T follicular helper stage favoring innate over adaptive germinal center responsesFrontiers in Immunology
accessLevelPublic
2019 348 204
Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantationAmerican Journal of Transplantation
accessLevelRestricted
2019 521 4
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical TrialClinical Infectious Diseases
accessLevelPublic
2019 324 313
Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homingFrontiers in Immunology
accessLevelPublic
2019 291 202
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including FormulationFrontiers in Immunology
accessLevelPublic
2019 278 238
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prisonJournal of Global Health
accessLevelPublic
2018 427 245
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
accessLevelPublic
2018 498 501
Prévention de la grippe en milieu de soins aigus : une intervention multimodaleRevue médicale suisse
accessLevelPublic
2018 470 254
Correlates of vaccine-induced protective immunity against Ebola virus diseaseSeminars in Immunology
accessLevelPublic
2018 677 368
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccinationNPJ Vaccines
accessLevelPublic
2018 420 172
Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein 180L Single-Nucleotide Polymorphism Is Associated With Susceptibility to Recurrent Pneumococcal Lower Respiratory Tract Infections in ChildrenFrontiers in Immunology
accessLevelPublic
2018 529 275
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyThe Lancet Infectious Diseases
accessLevelRestricted
2018 511 0
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?Expert Review of Vaccines
accessLevelPrivate
2018 367 0
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and AfricaScience Translational Medicine
accessLevelRestricted
2017 634 2
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
accessLevelPublic
2017 621 280
Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous surveyPLOS ONE
accessLevelPublic
2017 505 215
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
accessLevelRestricted
2017 462 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
accessLevelRestricted
2016 749 5
Clinical Management of Ebola Virus Disease in the United States and EuropeNew England Journal of Medicine
accessLevelPublic
2016 1,224 353
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhoodProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2016 659 2
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
accessLevelPublic
2016 932 275
Reply to Abu Raya et alClinical infectious diseases
accessLevelRestricted
2016 435 3
Vaccination in early life: standing up to the challengesCurrent Opinion in Immunology
accessLevelRestricted
2016 509 1
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJournal of Immunology
accessLevelRestricted
2016 550 2
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genesThe Journal of experimental medicine
accessLevelRestricted
2016 786 4
The 2014–2015 Ebola outbreak in West Africa: Hands OnAntimicrobial Resistance and Infection Control
accessLevelPublic
2016 542 237
Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccineVaccine
accessLevelRestricted
2016 583 3
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I studyVaccine
accessLevelRestricted
2015 531 0
The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector ImmunogenicityJournal of virology
accessLevelRestricted
2015 600 2
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
accessLevelRestricted
2015 705 0
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseasesSchweizerische medizinische Wochenschrift
accessLevelRestricted
2015 622 1
Protective efficacy of individual CD8+ T cell specificities in chronic viral infectionThe Journal of immunology
accessLevelRestricted
2015 628 0
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case reportLancet. Infectious diseases
accessLevelRestricted
2015 710 1
Ebola vaccine R&D: Filling the knowledge gapsScience translational medicine
accessLevelRestricted
2015 512 1
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
accessLevelRestricted
2015 678 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
accessLevelPublic
2015 617 206
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionPLOS pathogens
accessLevelPublic
2015 729 302
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyArthritis research & therapy
accessLevelPublic
2015 543 514
Bordetella holmesii: an under-recognised Bordetella speciesLancet. Infectious diseases
accessLevelRestricted
2014 736 0
Diagnosis of whooping cough in Switzerland: differentiating Bordetella pertussis from Bordetella holmesii by polymerase chain reactionPloS one
accessLevelPublic
2014 764 337
Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young childrenEuropean journal of clinical microbiology & infectious diseases
accessLevelPublic
2013 700 311
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenThe Pediatric infectious disease journal
accessLevelRestricted
2013 628 0
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young childrenJournal of leukocyte biology
accessLevelRestricted
2013 775 0
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newbornThe Pediatric infectious disease journal
accessLevelRestricted
2013 726 3
Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant childrenThe Pediatric infectious disease journal
accessLevelRestricted
2013 716 5
Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early lifePloS one
accessLevelPublic
2013 717 414
Calendrier vaccinal InfoVac pratique 2013Archives de pédiatrie
accessLevelRestricted
2013 651 6
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell nicheThe Journal of immunology
accessLevelRestricted
2012 609 0
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccineAntiviral therapy
accessLevelRestricted
2012 652 6
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*HIV medicine
accessLevelRestricted
2012 611 1
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?Current opinion in infectious diseases
accessLevelRestricted
2012 559 0
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in SwitzerlandClinical and vaccine immunology
accessLevelRestricted
2012 667 0
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patientsEuropean journal of pediatrics
accessLevelPublic
2012 708 299
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 549 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 576 0
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccinePloS one
accessLevelPublic
2012 773 341
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemiaClinical microbiology and infection
accessLevelRestricted
2012 592 0
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenicAmerican journal of transplantation
accessLevelRestricted
2012 796 1
Acceptability of maternal immunization against influenza: the critical role of obstetriciansJournal of maternal-fetal & neonatal medicine
accessLevelRestricted
2012 745 0
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionalsRevue d'épidémiologie et de santé publique
accessLevelRestricted
2012 727 3
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvantsThe Journal of immunology
accessLevelRestricted
2012 606 0
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsHIV medicine
accessLevelRestricted
2012 724 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 582 0
Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference centerPediatric transplantation
accessLevelRestricted
2012 702 0
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analogJournal of controlled release
accessLevelRestricted
2012 674 1
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatientsThe oncologist
accessLevelRestricted
2012 693 0
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responsesThe Journal of immunology
accessLevelRestricted
2012 708 0
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac diseaseJournal of pediatric gastroenterology and nutrition
accessLevelPublic
2012 636 461
Vaccinologie : nouvelles recommandations pour les rappels tétanos, diphtérie et coqueluche chez l'adulteRevue médicale suisse
accessLevelRestricted
2012 596 2
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination programPharmacoepidemiology and drug safety
accessLevelRestricted
2012 623 1
Bulletin spécial calendrier vaccinalArchives de pédiatrie
accessLevelRestricted
2011 512 2
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2011 557 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 1,052 618
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticlesBioconjugate chemistry
accessLevelPrivate
2011 651 0
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised childrenVaccine
accessLevelRestricted
2011 647 0
Challenges in infant immunity: implications for responses to infection and vaccinesNature immunology
accessLevelRestricted
2011 477 0
Vaccination during pregnancy to protect infants against influenza: why and why not?Vaccine
accessLevelRestricted
2011 612 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 878 8
Bulletin spécial semaine de la vaccination: rougeole avril no 4/2011 1Archives de pédiatrie
accessLevelRestricted
2011 421 0
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipientsAmerican journal of transplantation
accessLevelRestricted
2011 666 0
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaPharmacogenomics
accessLevelRestricted
2011 952 6
Neonatal immunization: where do we stand?Current opinion in infectious diseases
accessLevelRestricted
2011 515 2
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?Archives of neurology
accessLevelRestricted
2011 710 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2011 563 0
The next decade of vaccines: societal and scientific challengesLancet
accessLevelRestricted
2011 658 0
Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein AClinical microbiology and infection
accessLevelRestricted
2011 635 0
Bulletin infovacArchives de pédiatrie
accessLevelRestricted
2011 557 0
Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prisonSchweizerische medizinische Wochenschrift
accessLevelRestricted
2011 752 1
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experienceAgeing research reviews
accessLevelPublic
2011 714 1,182
Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoquesRevue médicale suisse
accessLevelRestricted
2011 494 1
Mode of action of adjuvants: implications for vaccine safety and designBiologicals
accessLevelRestricted
2010 637 0
Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1)Revue médicale suisse
accessLevelRestricted
2010 514 1
Glycoconjugate vaccines and immune interference: A reviewVaccine
accessLevelRestricted
2010 549 0
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunityNature medicine
accessLevelRestricted
2010 595 0
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?Vaccine
accessLevelRestricted
2010 579 0
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measuresScandinavian journal of infectious diseases
accessLevelRestricted
2010 726 3
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancyThe Journal of infectious diseases
accessLevelRestricted
2010 557 0
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected childrenArchives of disease in childhood
accessLevelRestricted
2010 692 0
Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countriesMedicine
accessLevelRestricted
2010 619 1
Booster vaccination after neonatal priming with acellular pertussis vaccineThe Journal of pediatrics
accessLevelRestricted
2010 592 0
B-cell responses to vaccination at the extremes of ageNature reviews. Immunology
accessLevelRestricted
2009 609 0
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trialsLancet
accessLevelRestricted
2009 674 0
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesLancet
accessLevelRestricted
2009 590 0
Impaired antibody response causes persistence of prototypic T cell-contained virusPLoS biology
accessLevelPublic
2009 754 738
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature"The Journal of immunology
accessLevelRestricted
2009 539 0
Vaccinologie : quel rattrapage pour les patients avec des vaccinations inconnues ou incomplètes ?Revue médicale suisse
accessLevelRestricted
2009 507 0
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theoriesVaccine
accessLevelRestricted
2009 663 0
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelinesEuropean journal of pediatrics
accessLevelRestricted
2009 695 0
Immunization and transplantation--what is new and what is coming?Pediatric transplantation
accessLevelRestricted
2009 506 0
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsPloS one
accessLevelPublic
2009 698 413
Allergies et vaccins : distinguer le vrai du fauxRevue médicale suisse
accessLevelRestricted
2009 505 0
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in SwitzerlandThe Pediatric infectious disease journal
accessLevelRestricted
2009 689 0
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablastsBlood
accessLevelRestricted
2008 691 0
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infantsThe Journal of pediatrics
accessLevelRestricted
2008 598 0
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseThe Journal of immunology
accessLevelRestricted
2008 600 2
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected childrenThe Pediatric infectious disease journal
accessLevelRestricted
2008 638 3
Rougeole : diagnostic et prise en charge d'une maladie toujours d'actualitéRevue médicale suisse
accessLevelRestricted
2008 666 0
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibodyClinical infectious diseases
accessLevelRestricted
2008 578 0
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cellsBlood
accessLevelRestricted
2008 671 0
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunizationThe Journal of pediatrics
accessLevelRestricted
2008 586 1
Actualités vaccinologiques pour 2008: quoi de neuf en Suisse ?Revue médicale suisse
accessLevelRestricted
2008 485 0
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cellsEuropean Journal of Immunology
accessLevelRestricted
2008 589 0
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniaeVaccine
accessLevelRestricted
2008 651 1
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantPloS one
accessLevelPublic
2008 652 402
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infantsThe Journal of pediatrics
accessLevelRestricted
2008 622 0
Autoimmune diseases after adolescent or adult immunization: what should we expect?CMAJ. Canadian Medical Association journal
accessLevelPublic
2007 529 269
Mechanisms underlying adverse reactions to vaccinesJournal of comparative pathology
accessLevelRestricted
2007 573 0
Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference centerPediatric transplantation
accessLevelRestricted
2007 649 0
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-upThe Journal of trauma
accessLevelRestricted
2007 523 0
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005Vaccine
accessLevelRestricted
2007 496 0
Atorvastatin treatment and vaccination efficacyJournal of clinical pharmacology
accessLevelRestricted
2007 611 0
Influence of anesthesia on immune responses and its effect on vaccination in children: review of evidencePaediatric anaesthesia
accessLevelRestricted
2007 627 2
Author's reply [Vaccination and anesthesia]Paediatric anaesthesia
accessLevelRestricted
2007 544 0
Vaccination des patients souffrant de maladies chroniques du foieRevue médicale suisse
accessLevelRestricted
2007 492 2
The challenges of vaccine responses in early life: selected examplesJournal of comparative pathology
accessLevelRestricted
2007 567 0
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cellsJournal of virology
accessLevelPublic
2007 577 477
Vaccinologie : Plan de vaccination suisse 2007 : première lectureRevue médicale suisse
accessLevelRestricted
2007 496 4
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactionsThe Pediatric infectious disease journal
accessLevelRestricted
2007 528 0
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Clinical and vaccine immunology
accessLevelPublic
2006 726 489
Actualités vaccinologiques 2005 : nouvelle catégorie de recommandations pour une protection vaccinale optimaleRevue médicale suisse
accessLevelRestricted
2006 496 0
Enhanced chickenpox exanthema in vaccine injection siteScandinavian journal of infectious diseases
accessLevelRestricted
2006 499 0
Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twinsVaccine
accessLevelRestricted
2006 556 0
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacyEuropean Journal of Immunology
accessLevelRestricted
2006 523 0
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survivalThe Journal of immunology
accessLevelPublic
2006 602 346
Les vaccins sous haute surveillance : effets indésirables des vaccins : questions posée et réponses apportées par InfoVacArchives de pédiatrie
accessLevelRestricted
2006 500 1
B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccinationVaccine
accessLevelRestricted
2006 632 0
Effect of month of vaccine administration on antibody responses in The Gambia and PakistanTM & IH. Tropical medicine and international health
accessLevelRestricted
2006 554 0
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infantsThe Journal of infectious diseases
accessLevelPublic
2006 588 389
Immunisation of premature infantsArchives of disease in childhood
accessLevelRestricted
2006 496 0
VaccinologieRevue médicale suisse
accessLevelRestricted
2005 451 0
Die Folgen einer ungenügenden Herdimmunität bei «pädiatrischen» Infektionskrankheiten - Beispiel einer MasernepidemieTherapeutische Umschau
accessLevelRestricted
2005 664 0
How do physicians immunize their own children? Differences among pediatricians and nonpediatriciansPediatrics
accessLevelRestricted
2005 520 0
Can successful vaccines teach us how to induce efficient protective immune responses?Nature medicine
accessLevelRestricted
2005 576 0
Infections récurrentes des voies respiratoires inférieures de l'enfant : quand et comment les investiguer ?Revue médicale suisse
accessLevelRestricted
2005 577 0
Vaccine safety controversies and the future of vaccination programsThe Pediatric infectious disease journal
accessLevelRestricted
2005 637 0
La vaccinologie, une science neuve aux prises avec les croyancesRevue médicale suisse
accessLevelRestricted
2005 443 0
Les adjuvants vaccinaux et la myofasciite à macrophagesArchives de pédiatrie
accessLevelRestricted
2005 574 1
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703FEMS immunology and medical microbiology
accessLevelPublic
2005 582 326
The advantage of mucosal immunization for polysaccharide-specific memory responses in early lifeEuropean Journal of Immunology
accessLevelRestricted
2005 434 0
Immunisation, immunomodulation et prévention des infections respiratoiresRevue médicale suisse
accessLevelRestricted
2005 484 0
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine SafetyAmerican journal of public health
accessLevelPublic
2004 580 735
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell typeVaccine
accessLevelRestricted
2004 704 0
Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responsesVaccine
accessLevelRestricted
2004 576 0
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseVaccine
accessLevelRestricted
2004 653 0
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory eventsThe Journal of pediatrics
accessLevelRestricted
2004 535 0
Genetic regulation of immune responses to vaccines in early lifeGenes and immunity
accessLevelRestricted
2004 551 0
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionMicrobes and infection
accessLevelRestricted
2004 548 0
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheresThe Journal of immunology
accessLevelPublic
2004 638 725
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adultsVaccine
accessLevelRestricted
2004 553 0
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic miceThe Journal of immunology
accessLevelRestricted
2004 602 0
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysThe American journal of tropical medicine and hygiene
accessLevelPublic
2004 980 1,209
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinantsVaccine
accessLevelRestricted
2003 455 0
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Vaccine
accessLevelRestricted
2003 552 0
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal miceVaccine
accessLevelRestricted
2003 633 0
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particlesVirology
accessLevelPublic
2003 614 390
Les adjuvants vaccinaux et la myofasciite à macrophagesBulletin de l'Académie nationale de médecine
accessLevelRestricted
2003 574 0
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidateVaccine
accessLevelRestricted
2003 588 0
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implicationsThe Journal of experimental medicine
accessLevelPublic
2003 516 919
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigensThe Journal of immunology
accessLevelPublic
2003 551 494
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothersThe Journal of immunology
accessLevelPublic
2003 616 539
Prévention vaccinale chez les adolescents : et s'il suffisait d'y penser ?Médecine et hygiène
accessLevelRestricted
2003 434 2
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cellsThe Journal of immunology
accessLevelPublic
2002 572 297
Polémiques de sécurité vaccinale : fin d'une histoire ou histoire sans fin ?Médecine et hygiène
accessLevelRestricted
2002 376 0
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccinesEuropean Journal of Immunology
accessLevelRestricted
2002 580 2
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal miceInfection and immunity
accessLevelPublic
2002 531 296
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussisInfection and immunity
accessLevelPublic
2002 588 300
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infectionThe Journal of infectious diseases
accessLevelRestricted
2002 582 0
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccinationThe Journal of immunology
accessLevelPublic
2002 561 341
Epidemiology of herpes simplex virus in children by detection of specific antibodies in salivaThe Pediatric infectious disease journal
accessLevelRestricted
2001 552 0
Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vectorVirology
accessLevelPublic
2001 594 326
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodiesFEMS immunology and medical microbiology
accessLevelPublic
2001 541 279
Neonatal and early life vaccinologyVaccine
accessLevelRestricted
2001 589 0
Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early lifeEuropean Journal of Immunology
accessLevelRestricted
2001 482 2
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?Archivum Immunologiae et Therapiae Experimentalis
accessLevelRestricted
2001 484 0
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigensImmunology
accessLevelPublic
2001 605 542
Infections récidivantes de l'enfant : quel dépistage immunitaire ?Archives de pédiatrie
accessLevelRestricted
2001 481 0
Nosocomial outbreak of multiple bloodborne viral infectionsThe Journal of infectious diseases
accessLevelPublic
2001 705 263
How to improve communication on vaccine issues at the national level? INFOVAC-PED: an example from SwitzerlandVaccine
accessLevelRestricted
2001 519 0
Detection of enteroviruses in the cerebrospinal fluid by polymerase chain reaction: prospective study of impact on the management of hospitalized childrenClinical pediatrics
accessLevelRestricted
2000 627 0
Expression of MHC class II molecules contributes to lipopolysaccharide responsivenessEuropean Journal of Immunology
accessLevelRestricted
2000 474 0
Vaccin contre la fièvre jaune : formellement contre-indiqué chez les transplantésMédecine et hygiène
accessLevelRestricted
2000 458 0
A brief view of known landmarks reorientates path integration in hamstersNaturwissenschaften
accessLevelRestricted
2000 606 0
Non, le vaccin contre l'hépatite B ne provoque pas la sclérose en plaques : retour sur un psychodrame collectifLa Recherche
accessLevelRestricted
2000 558 1
Quand et comment vacciner les prématurés ?Médecine et hygiène
accessLevelRestricted
2000 391 0
Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in miceEuropean Journal of Immunology
accessLevelRestricted
1999 523 0
Antigen-Presentation Systems, Immunomodulators, and Immune Responses to VaccinesHandbook of experimental pharmacology
accessLevelRestricted
1999 381 0
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussisLancet
accessLevelRestricted
1999 529 0
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal primingThe Journal of immunology
accessLevelPublic
1999 487 256
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study GroupAIDS
accessLevelRestricted
1998 467 0
Determinants of infant responses to vaccines in presence of maternal antibodiesVaccine
accessLevelRestricted
1998 480 0
Die Impfung gegen Hepatitis BSozial- und Präventivmedizin
accessLevelRestricted
1998 472 0
Quel avenir pour les vaccins ?Revue médicale de la Suisse romande
accessLevelRestricted
1998 465 0
Procalcitonin is a marker of severity of renal lesions in pyelonephritisPediatrics
accessLevelRestricted
1998 617 1
Hépatite B et sclérose en plaques : comment répondre aux inquiétudes du public ?Médecine et hygiène
accessLevelRestricted
1998 435 0
Influenza immunization: improving compliance of healthcare workersInfection control and hospital epidemiology
accessLevelRestricted
1998 525 0
Immunity in early lifeImmunology today
accessLevelRestricted
1998 483 0
New challenges for global immunizationSymposium in Immunology: Vol. VII : Vaccination
accessLevelRestricted
1998 483 0
Immunity in early life : an introduction [Proceedings of the International Symposium on Immunity in Early Life. Annecy, France, 17-19 November 1997]Vaccine
accessLevelRestricted
1998 481 0
Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?Vaccine
accessLevelRestricted
1998 551 0
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in miceEuropean Journal of Immunology
accessLevelRestricted
1998 566 0
Vaccination des sujets présentant un problème médical : précautions, contre-indicationsRevue médicale de la Suisse romande
accessLevelRestricted
1998 477 0
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulatorsImmunology and cell biology
accessLevelPublic
1998 492 587
Maternal immunity and infant responses to immunization : actors influencing infant responsesPreclinical and clinical development of new vaccines : proceedings of a symposium, Institut Pasteur, Paris, France, 27-28 May 1997
accessLevelRestricted
1998 411 0
Les vaccins contre l'hépatite BSozial- und Präventivmedizin
accessLevelRestricted
1998 581 0
Le développement de nouveaux vaccins à usage pédiatrique : progrès et défisRevue médicale de la Suisse romande
accessLevelRestricted
1998 471 0
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young miceProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
1998 577 717
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy childThe Pediatric infectious disease journal
1996 649 0
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promotersThe Journal of biological chemistry
accessLevelRestricted
1994 617 0
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
1994 602 0
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerMolecular and cellular biology
accessLevelRestricted
1993 602 0
Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oubliéSchweizerische medizinische Wochenschrift
1983 755 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack